Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Sunday. The brokerage issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 target price on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Stock Up 1.5 %

Shares of MLSS stock opened at $1.03 on Friday. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.10. The firm has a fifty day moving average of $0.84 and a 200-day moving average of $0.88. The firm has a market capitalization of $80.23 million, a price-to-earnings ratio of -14.71 and a beta of 1.10.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 24.75% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares in the last quarter. World Investment Advisors LLC bought a new position in shares of Milestone Scientific in the third quarter valued at $91,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific in the third quarter valued at $48,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.